245 related articles for article (PubMed ID: 3702867)
1. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. III. Catalytic act of trypsin and its inhibition].
Popov EM; Godzhaev NM; Aliev RE
Mol Biol (Mosk); 1986; 20(2):357-68. PubMed ID: 3702867
[TBL] [Abstract][Full Text] [Related]
2. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. I. Conformational properties of residues in the enzyme-active center and the structure of a non-valent enzyme-substrate complex].
Godzhaev NM; Aliev RE; Popov EM
Mol Biol (Mosk); 1986; 20(1):102-19. PubMed ID: 3951435
[TBL] [Abstract][Full Text] [Related]
3. [Conformational aspects of beta-trypsin interactions with substrates and pancreatic trypsin inhibitor. II. Structure of tetrahedral adducts and acylenzyme].
Aliev RE; Godzhaev NM; Popov EM
Mol Biol (Mosk); 1986; 20(2):346-56. PubMed ID: 3702866
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
5. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
[TBL] [Abstract][Full Text] [Related]
6. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
Azim MK; Grossmann JG; Zaidi ZH
J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
[TBL] [Abstract][Full Text] [Related]
7. Binding of the bovine pancreatic secretory trypsin inhibitor (Kazal) to bovine serine (pro)enzymes.
Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
J Mol Biol; 1987 Nov; 198(1):129-32. PubMed ID: 3430603
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic proteolytic enzymes of ostrich purified on immobilized protein inhibitors. Characterization of a new form of chymotrypsin (Chtr1).
Zelazko M; Chrzanowska J; Polanowski A
Comp Biochem Physiol B Biochem Mol Biol; 2008 Sep; 151(1):102-9. PubMed ID: 18598777
[TBL] [Abstract][Full Text] [Related]
10. [Determination and comparative analysis of the conformation of bovine pancreatic trypsin inhibitor and trypsin inhibitors E and K from the data of two-dimensional 1H-NMR spectroscopy].
Sherman SA; Andrianov AM
Mol Biol (Mosk); 1985; 19(5):1301-9. PubMed ID: 4079926
[TBL] [Abstract][Full Text] [Related]
11. Effects of proteinase--inhibitor binding on accessibility of exposed tyrosines. A photochemically induced dynamic nuclear polarization study of bovine pancreatic trypsin inhibitor complexes with trypsin, chymotrypsin, and their zymogens.
Muszkat KA; Weinstein S; Khait I; Vered M
Biochemistry; 1982 Aug; 21(16):3775-9. PubMed ID: 7138805
[No Abstract] [Full Text] [Related]
12. Design, chemical synthesis and kinetic studies of trypsin chromogenic substrates based on the proteinase binding loop of Cucurbita maxima trypsin inhibitor (CMTI-III).
Lesner A; Brzozowski K; Kupryszewski G; Rolka K
Biochem Biophys Res Commun; 2000 Mar; 269(1):81-4. PubMed ID: 10694481
[TBL] [Abstract][Full Text] [Related]
13. Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin.
Krokoszynska I; Dadlez M; Otlewski J
J Mol Biol; 1998 Jan; 275(3):503-13. PubMed ID: 9466927
[TBL] [Abstract][Full Text] [Related]
14. The crystal structures of the complexes between bovine beta-trypsin and ten P1 variants of BPTI.
Helland R; Otlewski J; Sundheim O; Dadlez M; Smalås AO
J Mol Biol; 1999 Apr; 287(5):923-42. PubMed ID: 10222201
[TBL] [Abstract][Full Text] [Related]
15. Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases.
Krowarsch D; Dadlez M; Buczek O; Krokoszynska I; Smalas AO; Otlewski J
J Mol Biol; 1999 May; 289(1):175-86. PubMed ID: 10339415
[TBL] [Abstract][Full Text] [Related]
16. Specific binding of human pancreatic secretory trypsin inhibitor to various cultured cells.
Niinobu T; Ogawa M; Shibata T; Murata A; Nishibe S; Mori T; Ogata N
Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):245-8. PubMed ID: 3489966
[TBL] [Abstract][Full Text] [Related]
17. Alanine point-mutations in the reactive region of bovine pancreatic trypsin inhibitor: effects on the kinetics and thermodynamics of binding to beta-trypsin and alpha-chymotrypsin.
Castro MJ; Anderson S
Biochemistry; 1996 Sep; 35(35):11435-46. PubMed ID: 8784199
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic secretory trypsin inhibitor, cathodal trypsin, and pancreatic elastase in pancreatic juice collected at endoscopic retrograde cholangiopancreatography.
Marks WH; Ohlsson K; Wehlin L; Russick C
Curr Surg; 1985; 42(1):26-8. PubMed ID: 3844336
[No Abstract] [Full Text] [Related]
19. X-ray crystallographic analyses of complexes between bovine beta-trypsin and Schiff base copper(II) or iron(III) chelates.
Toyota E; Ng KK; Sekizaki H; Itoh K; Tanizawa K; James MN
J Mol Biol; 2001 Jan; 305(3):471-9. PubMed ID: 11152605
[TBL] [Abstract][Full Text] [Related]
20. Interaction between serine (pro)enzymes, and Kazal and Kunitz inhibitors.
Antonini E; Ascenzi P; Bolognesi M; Gatti G; Guarneri M; Menegatti E
J Mol Biol; 1983 Apr; 165(3):543-58. PubMed ID: 6188849
[No Abstract] [Full Text] [Related]
[Next] [New Search]
